Labcorp Holdings (FRA:N6B) Days Sales Outstanding : 57.32 (As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Labcorp Holdings Days Sales Outstanding?

Labcorp Holdings's average Accounts Receivable for the three months ended in Mar. 2024 was €1,836 Mil. Labcorp Holdings's Revenue for the three months ended in Mar. 2024 was €2,922 Mil. Hence, Labcorp Holdings's Days Sales Outstanding for the three months ended in Mar. 2024 was 57.32.

The historical rank and industry rank for Labcorp Holdings's Days Sales Outstanding or its related term are showing as below:

FRA:N6B' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.76 Med: 49.64 Max: 65.87
Current: 60.56

During the past 13 years, Labcorp Holdings's highest Days Sales Outstanding was 65.87. The lowest was 42.76. And the median was 49.64.

FRA:N6B's Days Sales Outstanding is ranked better than
62.9% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.32 vs FRA:N6B: 60.56

Labcorp Holdings's Days Sales Outstanding declined from Mar. 2023 (62.32) to Mar. 2024 (57.32).

Labcorp Holdings Days Sales Outstanding Historical Data

The historical data trend for Labcorp Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labcorp Holdings Days Sales Outstanding Chart

Labcorp Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

47.03

54.45

63.42

60.08

56.29

Labcorp Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															62.32	64.33	57.22	58.86	57.32

Competitive Comparison of Labcorp Holdings's Days Sales Outstanding

For the Diagnostics & Research subindustry, Labcorp Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labcorp Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Days Sales Outstanding falls into.

Labcorp Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Labcorp Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1685.512	+	1754.496)	/	2 )	/	11152.187	*	365
=	1720.004					/	11152.187	*	365
=	56.29

Labcorp Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (1754.496	+	1917.004)	/	2 )	/	2922.472	*	365 / 4
=	1835.75					/	2922.472	*	365 / 4
=	57.32

Labcorp Holdings (FRA:N6B) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Labcorp Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Labcorp Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Labcorp Holdings (FRA:N6B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Labcorp Holdings Inc (FRA:N6B) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

LH:USA LH:Mexico L1CA34:Brazil

Address

358 South Main Street, Burlington, NC, USA, 27215

Website

https://www.labcorp.com

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Labcorp Holdings (FRA:N6B) Headlines

No Headlines